|
Quotes & Info
|
| CEMP > SEC Filings for CEMP > Form 8-K on 9-Oct-2012 | All Recent SEC Filings |
9-Oct-2012
Other Events, Financial Statements and Exhibits
On October 8, 2012, Cempra, Inc. issued a press release announcing results of its intravenous solithromycin Phase 1 study. A copy of the press release is attached as Exhibit 99.1.
(d) Exhibits
Exhibit
No. Description
99.1 Press Release issued October 8, 2012.
|
|